ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m<sup>6</sup>A modification, and drug susceptibility

Yongqi Ding; Yiyang Gong; Hong Zeng; Gelin Song; Zichuan Yu; Bidong Fu; Yue Liu; Da Huang; Yanying Zhong

doi:doi:10.18632/aging.204827

← Back

Research Paper Volume 15, Issue 13 pp 6179—6211

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m⁶A modification, and drug susceptibility

Figure 1. Study workflow. ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility.